Mediocre Vaccine Could Make Pandemic Worse, Non-Profit Group Tells US FDA

Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.

Mediocre street sign (source: shutterstock)
Stakeholders want to direct the US FDA's course ahead of VRBPAC on COVID-19 vaccines • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers